Alvotech (ICE:ALVO)
Iceland
· Delayed Price · Currency is ISK 1,125.00
0.00 (0.00%)
At close: Jun 25, 2025
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
76.67M ISK
Profits / Employee
12.59M ISK
Market Cap
340.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marel | 7,500 |
| Íslandsbanki | 764 |
| Arion banki | 822 |
| Sildarvinnslan Hf. | 723 |
| Brim hf. | 694 |
| Hagar | 2,699 |
| Kvika banki | 270 |
| Festi | 1,352 |
Alvotech News
- 2 days ago - Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility - GlobeNewsWire
- 3 days ago - Main Results of 2025 Annual and Extraordinary General Meeting - GlobeNewsWire
- 3 days ago - Main Results of 2025 Annual and Extraordinary General Meeting - GlobeNewsWire
- 3 days ago - Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab) - GlobeNewsWire
- 3 days ago - Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab) - GlobeNewsWire
- 5 days ago - European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept) - GlobeNewsWire
- 5 days ago - European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept) - GlobeNewsWire
- 17 days ago - Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Investors - GlobeNewsWire